Deutsche Märkte geschlossen

Olema Pharmaceuticals, Inc. (OLMA)

NasdaqGS - NasdaqGS Echtzeitpreis. Währung in USD
Zur Watchlist hinzufügen
10,82-0,03 (-0,28%)
Börsenschluss: 04:00PM EDT
10,98 +0,16 (+1,48%)
Nachbörse: 04:37PM EDT
Hauptinhaber
Insider

Insider-Transaktionen

Währung in USD
Insider-Käufe (letzte 6 Monate)AktienTrans
Käufe1.066.70013
Verkauf278.07413
Gekaufte Nettoaktien (verkauft)788.62626
Insideraktien mit Beteiligung (gesamt)2,2MN/A
% Gekaufte Nettoaktien (verkauft)55,80%N/A
Institutionelle Käufe (netto) der letzten QuartaleAktien
Gekaufte Nettoaktien (verkauft)N/A
% Schwankung in institutioneller AktienbeteiligungN/A

Gemeldete Insider-Transaktionen – Letzte zwei Jahre

InsiderTransaktionTypWertDatumAktien

HARMON CYRUS
Director

Sale at price 10.97 per share.Direkt219.40028. März 202420.000

ZOJWALLA NASEEM M.D.
Officer

Conversion of Exercise of derivative security at price 4.87 per share.Direkt66.71918. März 202413.700

HARMON CYRUS
Director

Sale at price 12.41 - 13.00 per share.Direkt310.30929. Feb. 202425.000

HARMON CYRUS
Director

Sale at price 12.23 - 15.56 per share.Direkt383.55001. Feb. 202430.000

ZOJWALLA NASEEM M.D.
Officer

Conversion of Exercise of derivative security at price 7.02 per share.Direkt140.40025. Jan. 202420.000

KOVACS SHANE WILLIAM CHARLES
Chief Operating Officer

Conversion of Exercise of derivative security at price 7.02 per share.Direkt351.00012. Jan. 202450.000

HARMON CYRUS
Director

Sale at price 13.30 - 14.10 per share.Direkt334.50029. Dez. 202325.000

KOVACS SHANE WILLIAM CHARLES
Chief Operating Officer

Conversion of Exercise of derivative security at price 7.02 per share.Direkt70.20012. Dez. 202310.000

ZOJWALLA NASEEM M.D.
Officer

Conversion of Exercise of derivative security at price 7.02 per share.Direkt20.35811. Dez. 20232.900

ZOJWALLA NASEEM M.D.
Officer

Conversion of Exercise of derivative security at price 7.02 per share.Direkt91.96206. Dez. 202313.100

PARADIGM BIOCAPITAL ADVISORS LP
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 11.60 per share.Indirekt1.160.00006. Dez. 2023100.000

WALMSLEY GRAHAM G
Director

Purchase at price 9.84 - 14.95 per share.Indirekt6.871.27905. Dez. 2023640.000

HARMON CYRUS
Director

Sale at price 12.57 per share.Direkt314.25030. Nov. 202325.000

KOVACS SHANE WILLIAM CHARLES
Chief Operating Officer

Sale at price 13.89 - 15.27 per share.Direkt269.65622. Nov. 202318.742

HARMON CYRUS
Director

Sale at price 13.90 - 14.86 per share.Direkt117.74022. Nov. 20238.181

MYLES DAVID C PH.D.
Officer

Sale at price 13.89 - 15.32 per share.Direkt196.23322. Nov. 202313.629

BOHEN SEAN
Chief Executive Officer

Sale at price 13.90 - 15.29 per share.Direkt824.13422. Nov. 202357.225

ZOJWALLA NASEEM M.D.
Officer

Sale at price 13.89 - 15.33 per share.Direkt209.29622. Nov. 202314.556

KOVACS SHANE WILLIAM CHARLES
Chief Operating Officer

Stock Award(Grant) at price 0.00 per share.Direkt020. Nov. 202336.750

HARMON CYRUS
Director

Stock Award(Grant) at price 0.00 per share.Direkt020. Nov. 202315.750

MYLES DAVID C PH.D.
Officer

Stock Award(Grant) at price 0.00 per share.Direkt020. Nov. 202326.250

BOHEN SEAN
Chief Executive Officer

Stock Award(Grant) at price 0.00 per share.Direkt020. Nov. 2023110.250

ZOJWALLA NASEEM M.D.
Officer

Stock Award(Grant) at price 0.00 per share.Direkt020. Nov. 202328.000

MYLES DAVID C PH.D.
Officer

Sale at price 17.61 per share.Direkt3.52208. Nov. 2023200

MYLES DAVID C PH.D.
Officer

Sale at price 15.02 - 17.51 per share.Direkt160.80603. Nov. 202310.541

HARMON CYRUS
Director

Sale at price 12.05 - 15.64 per share.Direkt379.45002. Nov. 202330.000

HARMON CYRUS
Director

Sale at price 12.41 per share.Direkt310.25029. Sept. 202325.000

MYLES DAVID C PH.D.
Officer

Sale at price 12.67 per share.Direkt253.40019. Sept. 202320.000

BVF PARTNERS L P
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 9.84 per share.Indirekt14.818.37112. Sept. 20231.505.932

HARMON CYRUS
Director

Sale at price 9.36 - 11.62 per share.Direkt256.60005. Sept. 202325.000

HARMON CYRUS
Director

Sale at price 10.14 per share.Direkt152.10016. Aug. 202315.000

HARMON CYRUS
Director

Sale at price 10.14 per share.Direkt152.10016. Aug. 202315.000

HARMON CYRUS
Director

Sale at price 6.30 per share.Direkt63.00008. Juni 202310.000

HARMON CYRUS
Director

Sale at price 6.04 - 6.29 per share.Direkt61.70006. Juni 202310.000

KOVACS SHANE WILLIAM CHARLES
Chief Operating Officer

Purchase at price 3.29 per share.Direkt32.90006. Apr. 202310.000

BOHEN SEAN
Chief Executive Officer

Stock Award(Grant) at price 0.00 per share.Direkt021. Sept. 202220.000

BOHEN SEAN
Chief Executive Officer

Purchase at price 2.97 per share.Direkt59.40021. Sept. 202220.000

KOVACS SHANE WILLIAM CHARLES
Chief Operating Officer

Purchase at price 3.47 per share.Direkt69.40002. Sept. 202220.000

BVF PARTNERS L P
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 4.03 per share.Indirekt806.90010. Juni 2022200.000

HORN KINNEY
Officer

Sale at price 4.75 per share.Direkt24.95210. März 20225.253

HORN KINNEY
Officer

Conversion of Exercise of derivative security at price 2.06 per share.Direkt10.84210. März 20225.253

HORN KINNEY
Officer

Conversion of Exercise of derivative security at price 2.06 per share.Direkt10.83810. Feb. 20225.251

HORN KINNEY
Officer

Sale at price 6.85 per share.Direkt35.96910. Jan. 20225.251

HORN KINNEY
Officer

Conversion of Exercise of derivative security at price 2.06 per share.Direkt10.83810. Jan. 20225.251

MYLES DAVID C PH.D.
Officer

Sale at price 10.30 per share.Direkt103.00010. Dez. 202110.000

HORN KINNEY
Officer

Sale at price 10.39 per share.Direkt54.55810. Dez. 20215.251

HORN KINNEY
Officer

Conversion of Exercise of derivative security at price 2.06 per share.Direkt10.83810. Dez. 20215.251

BVF PARTNERS L P
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 9.39 per share.Indirekt6.945.77030. Nov. 2021739.675

HARMON CYRUS
Chief Technology Officer

Sale at price 24.76 per share.Direkt9.90429. Nov. 2021400

HORN KINNEY
Officer

Sale at price 26.88 per share.Direkt743.71610. Nov. 202127.668

HORN KINNEY
Officer

Conversion of Exercise of derivative security at price 2.06 - 19.00 per share.Direkt436.76110. Nov. 202127.668

HARMON CYRUS
Chief Technology Officer

Sale at price 27.85 - 28.20 per share.Direkt335.79419. Okt. 202112.000

BOHEN SEAN
Chief Executive Officer

Sale at price 30.42 - 31.17 per share.Direkt152.36314. Okt. 20215.000

BOHEN SEAN
Chief Executive Officer

Conversion of Exercise of derivative security at price 4.82 per share.Direkt24.12014. Okt. 20215.000

HORN KINNEY
Officer

Sale at price 27.47 - 28.19 per share.Direkt146.51011. Okt. 20215.251

HORN KINNEY
Officer

Conversion of Exercise of derivative security at price 2.06 per share.Direkt10.83811. Okt. 20215.251

BOHEN SEAN
Chief Executive Officer

Sale at price 30.07 per share.Direkt32.62627. Sept. 20211.085

BOHEN SEAN
Chief Executive Officer

Conversion of Exercise of derivative security at price 4.82 per share.Direkt5.23427. Sept. 20211.085

HARMON CYRUS
Chief Technology Officer

Sale at price 26.30 per share.Direkt315.60020. Sept. 202112.000

HORN KINNEY
Officer

Sale at price 29.38 per share.Direkt154.27410. Sept. 20215.251

HORN KINNEY
Officer

Conversion of Exercise of derivative security at price 2.06 per share.Direkt10.83810. Sept. 20215.251

BOHEN SEAN
Chief Executive Officer

Sale at price 30.00 - 30.08 per share.Direkt91.35308. Sept. 20213.044

BOHEN SEAN
Chief Executive Officer

Conversion of Exercise of derivative security at price 4.82 per share.Direkt14.68408. Sept. 20213.044

BOHEN SEAN
Chief Executive Officer

Sale at price 30.05 per share.Direkt26.17401. Sept. 2021871

BOHEN SEAN
Chief Executive Officer

Conversion of Exercise of derivative security at price 4.82 per share.Direkt4.20201. Sept. 2021871

HARMON CYRUS
Chief Technology Officer

Sale at price 24.97 per share.Direkt299.64019. Aug. 202112.000

HORN KINNEY
Officer

Sale at price 25.70 - 26.17 per share.Direkt134.97910. Aug. 20215.251

HORN KINNEY
Officer

Conversion of Exercise of derivative security at price 2.06 per share.Direkt10.83810. Aug. 20215.251

HARMON CYRUS
Chief Technology Officer

Sale at price 24.83 - 25.63 per share.Direkt301.25820. Juli 202112.000

HORN KINNEY
Officer

Sale at price 26.33 - 27.00 per share.Direkt139.19112. Juli 20215.251

HORN KINNEY
Officer

Conversion of Exercise of derivative security at price 2.06 per share.Direkt10.83812. Juli 20215.251

HARMON CYRUS
Chief Technology Officer

Sale at price 24.54 - 26.30 per share.Direkt297.62618. Juni 202112.000

HORN KINNEY
Officer

Sale at price 28.30 - 29.97 per share.Direkt156.07110. Juni 20215.251

HORN KINNEY
Officer

Conversion of Exercise of derivative security at price 2.06 per share.Direkt10.83810. Juni 20215.251

HORN KINNEY
Officer

Sale at price 24.03 - 24.81 per share.Direkt1.394.76918. Mai 202157.763

HORN KINNEY
Officer

Conversion of Exercise of derivative security at price 2.06 per share.Direkt119.22318. Mai 202157.763

RAPPAPORT ANDREW S
Director

Indirekt23. Nov. 2020448.556

MCCORMICK FRANK
Director

Indirekt23. Nov. 2020219.217

CORMORANT ASSET MANAGEMENT ,L.P
Former

Purchase at price 52.78 per share.Indirekt22.431.50023. Nov. 2020425.000

CORMORANT ASSET MANAGEMENT ,L.P
Former

Indirekt23. Nov. 20202.845.544

WALMSLEY GRAHAM G
Director

Purchase at price 48.90 per share.Indirekt56.724.00023. Nov. 20201.160.000

WALMSLEY GRAHAM G
Director

Indirekt23. Nov. 20202.583.875

WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS CAYMAN I L
Beneficial Owner of more than 10% of a Class of Security

Direkt23. Nov. 20201.725.406

KUSHNER PETER J PH.D.
Officer

Direkt23. Nov. 2020358.920

HARMON CYRUS
Chief Technology Officer

Indirekt23. Nov. 2020193.402

MYLES DAVID C PH.D.
Officer

Indirekt23. Nov. 2020167.677

BOHEN SEAN
Chief Executive Officer

Conversion of Exercise of derivative security at price 4.82 per share.Direkt249.15523. Sept. 202051.649

BUTITTA CYNTHIA M
Director

Conversion of Exercise of derivative security at price 4.41 per share.Direkt369.55816. Sept. 202083.876

KOVACS SHANE WILLIAM CHARLES
Chief Operating Officer

Direkt15. Juni 2020358.680

KUSHNER PETER J PH.D.
Officer

Direkt15. Juni 2020143.472

HARMON CYRUS
Chief Technology Officer

Direkt15. Juni 2020143.472

MYLES DAVID C PH.D.
Officer

Direkt15. Juni 2020143.472